$32.73
+0.74(2.31%)
Mkt Cap $1.9B
$5.90
$38.35
52-Week Range
At A Glance
1
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United ...
2
Revenue is primarily driven by License (80.3%) and Service (19.7%).
3
Most recently: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 1 (2026-03-03).
$1.9B
Market Cap
$187M
Revenue
-$7M
Net Income
Employees128
Fundamentals
How The Business Makes Money
Revenue by Segment
License80.3%($29M)
Service19.7%($7M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001623526
ISINUS86150R1077
CUSIP86150R107
Phone781 430 8200
Address45 Wiggins Avenue, Bedford, MA, 01730, US
SEC EDGAR